Form 4 for MNPR Monopar Therapeutics
Accepted 2024-06-21 00:00:00 ET · period of report 2024-06-18 · accession 0001437749-24-021000 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-21 | 2024-06-18+ | MNPR | Cittadine Andrew | COO | P - Purchase | $0.7843 | +32.5K | 186.1K | +21% | +$25.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-18 | P | A | 12,000 | $0.86 | 165,624 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-20 | P | A | 20,508 | $0.74 | 186,132 | D | — | — |